Disease Subtype(s) HCT Disease Inserts required Cellular Therapy Disease Inserts required
B-lymphoblastic leukemia / lymphoma
  • B-lymphoblastic leukemia / lymphoma, NOS (B-cell ALL, NOS) (191)
  • B-lymphoblastic leukemia / lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 (192)
  • B-lymphoblastic leukemia / lymphoma with t(v;11q23.3); KMT2A rearranged (193)
  • B-lymphoblastic leukemia / lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 (194)
  • B-lymphoblastic leukemia / lymphoma with t(12;21) (p13.2;q22.1); ETV6-RUNX1 (195)
  • B-lymphoblastic leukemia / lymphoma with t(5;14) (q31.1;q32.3); IL3-IGH (81)
  • B-lymphoblastic leukemia / lymphoma with Hyperdiploidy (51-65 chromosomes) (82)
  • B-lymphoblastic leukemia / lymphoma with Hypodiploidy (<45 chromosomes) (83)
  • B-lymphoblastic leukemia / lymphoma, BCR-ABL1-like (provisional entity) (94)
  • B-lymphoblastic leukemia / lymphoma, with iAMP21 (provisional entity) (95)
  • T-cell lymphoblastic leukemia / lymphoma
  • Early T-cell precursor lymphoblastic leukemia (provisional entity) (96)
  • Natural killer (NK)- cell lymphoblastic leukemia / lymphoma (provisional entity) (97)
Form 2011 & 2111 Form 2011/2011
Last modified: 2017/06/27

Feedback

Was this helpful?

Yes No
You indicated this topic was not helpful to you ...
Could you please leave a comment telling us why? Thank you!
Thanks for your feedback.

Post your comment on this topic.

Please do not use this for support questions.
For customer support, please contact us here.

Post Comment